KVUE vs PG: Which Is the Better Buy in 2026?
Last updated October 2026
Short answer
PG is the larger of the two ($370.40B market cap): the incumbent the market prices for continued execution (21.56x forward earnings, beta 0.38). KVUE is the smaller challenger ($36.32B), cheaper on forward earnings (15.26x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
KVUE vs PG: the tie-breaker metrics
Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | KVUE | PG | What it tells you |
|---|---|---|---|
| Market cap | $36.32B | $370.40B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 15.26 | 21.56 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 21.99 | 24.07 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.45 | 0.38 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 80% of range | 73% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 3.44 | 6.94 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: KVUE is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how KVUE and PG affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. KVUE and PG share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined KVUE and PG exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Kenvue (KVUE) do?
Kenvue is the world's largest pure-play consumer health company, spun off from Johnson & Johnson in 2023, and it is now in the process of being acquired by Kimberly-Clark, the maker of Huggies, Kleenex, and Kotex. The two companies signed a merger agreement on November 2, 2025 under which each Kenvue share is to be converted into $3.50 in cash plus 0.14625 of a Kimberly-Clark share, a combination valued at about $48.7 billion when it was announced. In October 2026 the European Commission approved the deal on condition that Kimberly-Clark sell its Kotex, Camelia, and Record feminine-hygiene brands in the European Economic Area (to Dilek Grup), and in August 2026 Kenvue agreed to sell its feminine-care business in Brazil to Essity for about $284 million, a sale Brazil's competition authority has cleared. On September 28, 2026 Kimberly-Clark launched exchange offers for up to $7.0 billion of Kenvue notes, conditioned on the merger, which it expects to complete in the fourth quarter of calendar 2026.
What does Procter & Gamble (PG) do?
Procter & Gamble is one of the world's largest consumer-products companies, selling everyday household and personal-care brands used by billions of people. Its portfolio is organized into segments spanning fabric and home care (Tide, Ariel, Downy, Dawn, Febreze), baby, feminine, and family care (Pampers, Always, Bounty, Charmin), beauty (Olay, Pantene, Head & Shoulders, SK-II), grooming (Gillette, Venus), and health care (Crest, Oral-B, Vicks, Metamucil). P&G makes money selling these branded products through retailers, e-commerce, and other channels worldwide, relying on scale, marketing, and continual product innovation to command premium pricing and shelf space. The company deliberately pruned its portfolio over the past decade to focus on a smaller set of large, profitable, daily-use categories. Founded in 1837 and headquartered in Cincinnati, Ohio, P&G is a classic defensive blue chip and a Dividend King, prized for steady cash flow, pricing power, and an exceptionally long record of dividend increases.
KVUE vs PG: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- KVUE drivers: What holders receive at closing; Regulatory path and timing.
- PG drivers: Brand strength and pricing power; Defensive, recurring demand.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The main risks are now deal risks. For PG, p&G's mature categories grow slowly, so organic growth depends on modest pricing and volume gains; in a low-inflation environment, raising prices further is harder and volumes can soften if shoppers trade down to private-label alternatives.
KVUE or PG: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick KVUE if you believe its drivers more; PG if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the KVUE and PG guides.
KVUE vs PG: the full fundamentals
KVUE. Kenvue no longer trades on its own fundamentals: with a signed merger agreement and conditional EU approval, the KVUE price reflects $3.50 of cash plus 0.14625 of a Kimberly-Clark share, minus a discount for time and the chance the deal fails. The trailing and forward multiples above describe the business Kimberly-Clark is buying rather than what drives the stock day to day.
PG. P&G is a high-margin, cash-rich consumer-staples leader that commands a premium valuation for its brand strength, defensiveness, and unmatched dividend record. At $159.10 in mid-October 2026 it trades around 24 times trailing and 21.5 times forward earnings while consensus calls for roughly flat EPS in fiscal 2027, so the price leans on stability and capital return rather than growth. The fiscal Q1 2027 report on October 22 (consensus EPS about $1.89 on $22.8 billion of revenue) is the next test.
Headline figures (approximate, October 2026): KVUE shows deal consideration (per kvue share) $3.50 cash + 0.14625 KMB shares, expected closing Q4 2026 (per Kimberly-Clark), revenue (ttm) ~$15.4 billion (Q2 up ~3% YoY), net income (ttm) ~$1.66 billion; PG shows revenue (fiscal 2026) ~$87 billion, +1.5% yoy in the June quarter, operating margin ~22%, net margin ~18% (~$16 billion net income), free cash flow ~$13.3 billion (TTM).
The bottom line: KVUE vs PG
KVUE and PG are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined KVUE and PG exposure against your real portfolio. It is not an investment adviser.
Wondering how KVUE or PG fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Kenvue with AI
Connect the broker you already use and ask Walnut's AI how KVUE fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between KVUE and PG?
+
Kenvue is the world's largest pure-play consumer health company, spun off from Johnson & Johnson in 2023, and it is now in the process of being acquired by Kimberly-Clark, the maker of Huggies, Kleenex, and Kotex. Procter & Gamble is one of the world's largest consumer-products companies, selling everyday household and personal-care brands used by billions of people. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is KVUE or PG the better stock?
+
Neither is universally better. PG is the larger incumbent; KVUE is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, KVUE or PG?
+
On forward P/E (as of October 2026), KVUE trades at 15.26x and PG at 21.56x, so KVUE is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both KVUE and PG?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of KVUE vs PG?
+
KVUE: The main risks are now deal risks. Closing could be delayed or fail if remaining regulatory conditions are not met, and a failed deal would likely send KVUE back toward a standalone valuation. Because most of the consideration is Kimberly-Clark stock, a fall in KMB shares directly lowers what a Kenvue holder receives; Kimberly-Clark shares had fallen about 13% according to an October 2026 report. The combined company takes on Kenvue's inherited litigation, including Tylenol and talc-related claims, plus integration risk and added debt from the cash portion. Until closing, Kenvue's own operations still carry private-label competition, input-cost inflation, and currency exposure, and its latest quarter showed only about 3% revenue growth with EPS slightly below estimates. PG: P&G's mature categories grow slowly, so organic growth depends on modest pricing and volume gains; in a low-inflation environment, raising prices further is harder and volumes can soften if shoppers trade down to private-label alternatives. That slowdown is now visible: revenue grew only about 1.5% year over year in the latest quarter, and analysts expect fiscal 2027 revenue of about $88.9 billion and EPS of about $6.98, roughly 1% growth, with the September-quarter consensus of $1.89 down about 5% from a year earlier. A large share of sales comes from outside the US, exposing earnings to a strong dollar and emerging-market currency swings. Input-cost inflation (commodities, energy, transportation) can pressure margins. Private-label competition and shifting retailer dynamics, including the bargaining power of large retailers, are persistent threats. The defensive profile also means the stock can lag sharply in strong bull markets, and its premium valuation (about 24 times trailing earnings) leaves little room for execution missteps.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell KVUE or PG; figures are approximate and dated (as of October 2026). Verify current data before investing.